| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |